We are live on ! Find out more
RZH

Relyea Zuckerberg Hanson Portfolio holdings

AUM $1.2B
1-Year Est. Return 28.45%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+28.45%
3 Year Est. Return
+84.44%
5 Year Est. Return
+83.98%
10 Year Est. Return
AUM
$276M
AUM Growth
+$18.3M
Cap. Flow
+$31.3M
Cap. Flow %
11.35%
Top 10 Hldgs %
52.22%
Holding
152
New
9
Increased
83
Reduced
33
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 8.08%
2 Financials 4.07%
3 Industrials 3.36%
4 Consumer Discretionary 2.2%
5 Healthcare 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGT icon
51
Vanguard Information Technology ETF
VGT
$139B
$988K 0.36%
19,640
+1,288
+7% +$70.7K
PFF icon
52
iShares Preferred and Income Securities ETF
PFF
$13.3B
$974K 0.35%
+25,600
New +$995K
QQQ icon
53
Invesco QQQ Trust
QQQ
$453B
$946K 0.34%
2,690
-835
-24% -$322K
PG icon
54
Procter & Gamble
PG
$336B
$931K 0.34%
5,726
+516
+10% +$76.6K
XLY icon
55
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
$917K 0.33%
10,164
III icon
56
Information Services Group
III
$198M
$909K 0.33%
143,575
+68,575
+91% +$552K
UNP icon
57
Union Pacific
UNP
$174B
$894K 0.32%
3,630
+213
+6% +$50.5K
IHI icon
58
iShares US Medical Devices ETF
IHI
$3.13B
$887K 0.32%
14,994
XLI icon
59
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$880K 0.32%
8,700
CB icon
60
Chubb
CB
$135B
$870K 0.32%
4,529
+80
+2% +$15K
XLC icon
61
State Street Communication Services Select Sector SPDR ETF
XLC
$22.2B
$802K 0.29%
11,099
VOT icon
62
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.3B
$780K 0.28%
3,629
+487
+15% +$123K
MA icon
63
Mastercard
MA
$506B
$769K 0.28%
2,165
+152
+8% +$52.6K
ABBV icon
64
AbbVie
ABBV
$445B
$759K 0.28%
5,753
+566
+11% +$66.9K
COST icon
65
Costco
COST
$423B
$743K 0.27%
1,542
+151
+11% +$77.3K
GS icon
66
Goldman Sachs
GS
$301B
$734K 0.27%
+2,135
New +$845K
PPG icon
67
PPG Industries
PPG
$24.6B
$727K 0.26%
4,696
-73
-2% -$11.7K
MCD icon
68
McDonald's
MCD
$192B
$709K 0.26%
2,785
+1,149
+70% +$290K
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$66.7B
$709K 0.26%
11,794
+15
+0.1% +$928
YUM icon
70
Yum! Brands
YUM
$42.4B
$681K 0.25%
5,482
+53
+1% +$6.78K
TSLA icon
71
Tesla
TSLA
$1.23T
$679K 0.25%
2,157
+354
+20% +$119K
IJR icon
72
iShares Core S&P Small-Cap ETF
IJR
$110B
$669K 0.24%
6,385
AMAT icon
73
Applied Materials
AMAT
$409B
$664K 0.24%
4,917
+972
+25% +$141K
BSX icon
74
Boston Scientific
BSX
$68.9B
$657K 0.24%
15,299
-5,899
-28% -$248K
ESGE icon
75
iShares ESG Aware MSCI EM ETF
ESGE
$6.59B
$656K 0.24%
16,444
-2,619
-14% -$108K

Similar funds

Relyea Zuckerberg Hanson's Q4 2021 Portfolio in Review

As of Q4 2021, Relyea Zuckerberg Hanson held 152 positions worth $276M, up 7.1% from $257M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Relyea Zuckerberg Hanson deployed $31.3M of net new capital in Q4 2021, opening 9 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 3,783 shares worth $1.66M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 6.8% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was ARK Web x.0 ETF, an estimated $1.44M trimmed.

  • Relyea Zuckerberg Hanson's largest Q4 2021 buy was iShares Core S&P 500 ETF: 3,783 shares worth $1.66M.
  • Relyea Zuckerberg Hanson added most to Vanguard Morningstar Value ETF in Q4 2021, an estimated $9.93M increase.
  • Relyea Zuckerberg Hanson's biggest Q4 2021 reduction was ARK Web x.0 ETF, cutting an estimated $1.44M.
  • Relyea Zuckerberg Hanson fully exited BlackRock Health Sciences Trust II in Q4 2021, selling an estimated $579K.
  • Relyea Zuckerberg Hanson's ten largest holdings make up 52% of its $276M portfolio in Q4 2021.
  • Relyea Zuckerberg Hanson opened 9 new positions and closed 7 in Q4 2021.
  • Relyea Zuckerberg Hanson's portfolio value rose 7.1% quarter-over-quarter to $276M.

Based on Relyea Zuckerberg Hanson's 13F filing for Q4 2021, filed 14 Jan 2022.